Mast Therapeutics, Inc. SVRA 深 滬
已收盤 08-08 16:00:00 美东时间
2.64
+0.010
+0.38%
華盛通- 最 高2.705
- 今 開2.64
- 成交量 43.40万股
- 最 低 2.595
- 昨 收 2.63
- 總市值 4.57亿
- 52周最高 4.70
- 市盈率 靜 --
- 換手率 0.25%
- 52周最低 1.89
- 委 比 84.31%
- 總股本 1.73亿
- 歷史最高 17.187
- 量 比 0.59
- 振 幅 4.18%
- 歷史最低 0.69
- 每 手 1
- 風險率 0.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Savara Re-elects Board Members at Annual Meeting
Savara ( ($SVRA) ) has provided an announcement. On June 5, 2025, Savara Inc. h...
06-07 05:23
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
美股大行评级 | 拼多多遭多家大行下调评级！Redburn Atlantic首予博通"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1134767544930545665.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持AnaptysBio(ANAB)"买入"评级，目标价从54美元升至90美元</p> <p>• Canaccord Genuity：维持Bridger Aerospace Gr(BAER)"买入"评
05-29 09:53
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares rose 60.0% to $0.64 during Tuesday's regul...
05-28 01:05
Savara shares are trading lower after the company announced it received a refusal to file letter from the FDA for its biologics license application.
Savara shares are trading lower after the company announced it received a refus...
05-27 20:30
Savara Faces FDA Setback for MOLBREEVI Application
Savara ( ($SVRA) ) has issued an announcement. On May 27, 2025, Savara Inc. ann...
05-27 20:27
Hercules Capital declares $0.47 dividend
Hercules Capital (NYSE:HTGC) declares $0.40/share base quarterly and 0.07 supplemental dividend, in line with previous. Forward yield 10.47% Payable May 20; for shareholders of record May 13; ex-div ...
04-30 01:10
美股大行评级 | 潜在涨幅686.94%！Sensei Biotherapeutics获Oppenheimer升目标价至4美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级，目标价从3.5美元升至4美元</p> <p>• 富国银行：上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
HC Wainwright & Co. Reiterates Buy on Savara, Maintains $6 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Savara (NASDAQ:SVRA) with a Buy and maintains $6 price target.
03-28 19:00
